Aldevron LLC, a company angling for a role in the production of Covid-19 vaccines, hired Rachel Lei as its first general counsel and corporate secretary.
Lei became Aldevron’s first general counsel in June. She joins new chief executive officer Kevin Ballinger, hired the following month, among other recent additions to the North Dakota-based company’s leadership team.
“I want to try to maintain what has made Aldevron so successful, which is an incredibly service-based mentality,” she told Bloomberg Law. “We really exist in the service of the science community to advance treatments and cures for a lot of terrible diseases.”
Aldevron is the world’s largest producer of plasmids, or circular strands of DNA widely used in gene therapy and vaccine production. The company expects a spike in demand when a Covid-19 vaccine is eventually approved.